💨 Abstract

South Africa has approved Lenacapavir, an innovative HIV prevention injection, marking a significant milestone in the fight against HIV/AIDS. The drug, developed by Gilead Sciences, offers protection for up to six months with just one injection, making it a game-changer for HIV prevention. The South African Health Products Regulatory Authority (SAHPRA) and Health Minister Dr. Aaron Motsoaledi have highlighted its potential to close gaps in existing prevention methods.

Courtesy: Nick Pawson